Oct 23, 2017
EnteroMedics Announces Name Change to ReShape Lifesciences Inc. (NASDAQ: RSLS)
Oct 16, 2017
EnteroMedics Announces Presentations at ObesityWeek 2017
Oct 12, 2017
EnteroMedics Announces New Employee Inducement Option Grants
Sep 12, 2017
EnteroMedics to Present at the Ladenburg Thalmann 2017 Healthcare Conference
Sep 05, 2017
EnteroMedics Begins Post-Approval Study for the Treatment of Obesity with vBloc Therapy
Aug 28, 2017
Study Concludes Vagal Nerve Blocking with EnteroMedics' vBloc Therapy is Cost-Effective
Aug 21, 2017
EnteroMedics Announces First Veterans Choice Program vBloc® Implant at MedStar Health in Maryland
Aug 16, 2017
EnteroMedics Announces Presentations Highlighting vBloc and Gastric Vest at IFSO Annual Conference
Aug 11, 2017
EnteroMedics Announces Pricing of $20 Million Underwritten Public Offering
Aug 10, 2017
EnteroMedics Announces Proposed Underwritten Public Offering
Aug 08, 2017
EnteroMedics Announces Second Quarter 2017 Financial Results
Aug 02, 2017
EnteroMedics To Discuss Business Strategy And Financial Results For The Second Quarter Of 2017
Jul 31, 2017
EnteroMedics Receives Approval for Gastric Vest System Clinical Study in Spain
Jul 25, 2017
EnteroMedics Announces First Veterans Choice Program vBloc® Implant for Obesity at Methodist Dallas Medical Center
Jul 20, 2017
EnteroMedics Announces Receipt of European Patent Certificate
Jun 28, 2017
EnteroMedics Announces Affordable vBloc® Therapy Program for Weight Loss Patients
Jun 26, 2017
EnteroMedics Added to Russell Microcap® Index
Jun 21, 2017
EnteroMedics Announces vBloc Therapy to be Presented by Keynote Speaker at Major International Obesity Conference
Jun 02, 2017
Medical Equipment Stocks on Investors' Radar -- Abbott Labs, Boston Scientific, Medtronic, and EnteroMedics
May 31, 2017
EnteroMedics Announces First vBloc® Neurometabolic Therapy Implant at AMITA Health Adventist Medical Center Bolingbrook